These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 10096521
1. Temporal sequence of transcription of perforin, Fas ligand, and tumor necrosis factor-alpha genes in rejecting skin allografts. Borson ND, Strausbauch MA, Kennedy RB, Oda RP, Landers JP, Wettstein PJ. Transplantation; 1999 Mar 15; 67(5):672-80. PubMed ID: 10096521 [Abstract] [Full Text] [Related]
2. Apoptosis is involved in acute cardiac allograft rejection in rats. Kageyama Y, Li XK, Suzuki S, Suzuki H, Suzuki K, Kazui T, Harada Y. Ann Thorac Surg; 1998 Jun 15; 65(6):1604-9. PubMed ID: 9647066 [Abstract] [Full Text] [Related]
3. Cytotoxic pathways in the skin allograft rejection by CD4+ T cells. Ito A, Minagawa M, Tomiyama K, Ito M, Kawai K. Transplantation; 1999 Jul 15; 68(1):97-100. PubMed ID: 10428275 [Abstract] [Full Text] [Related]
4. Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing. Komatsu M, Mammolenti M, Jones M, Jurecic R, Sayers TJ, Levy RB. Blood; 2003 May 15; 101(10):3991-9. PubMed ID: 12521999 [Abstract] [Full Text] [Related]
5. Analysis of effector mechanisms in murine cardiac allograft rejection. Alexander DZ, Pearson TC, Hendrix R, Ritchie SC, Larsen CP. Transpl Immunol; 1996 Mar 15; 4(1):46-8. PubMed ID: 8762009 [Abstract] [Full Text] [Related]
6. Acute rejection of allografted CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient mice. Nomi H, Tashiro-Yamaji J, Yamamoto Y, Miura-Takeda S, Miyoshi-Higashino M, Takahashi T, Azuma H, Ueda H, Katsuoka Y, Kubota T, Yoshida R. J Immunol; 2007 Aug 15; 179(4):2180-6. PubMed ID: 17675477 [Abstract] [Full Text] [Related]
7. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts. Taylor MA, Ward B, Schatzle JD, Bennett M. Eur J Immunol; 2002 Mar 15; 32(3):793-9. PubMed ID: 11870623 [Abstract] [Full Text] [Related]
8. Molecular executors of cell death--differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts. Sharma VK, Bologa RM, Li B, Xu GP, Lagman M, Hiscock W, Mouradian J, Wang J, Serur D, Rao VK, Suthanthiran M. Transplantation; 1996 Dec 27; 62(12):1860-6. PubMed ID: 8990377 [Abstract] [Full Text] [Related]
9. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL. Lee SH, Bar-Haim E, Machlenkin A, Goldberger O, Volovitz I, Vadai E, Tzehoval E, Eisenbach L. Cancer Gene Ther; 2004 Mar 27; 11(3):237-48. PubMed ID: 14739939 [Abstract] [Full Text] [Related]
10. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin. Seki N, Brooks AD, Carter CR, Back TC, Parsoneault EM, Smyth MJ, Wiltrout RH, Sayers TJ. J Immunol; 2002 Apr 01; 168(7):3484-92. PubMed ID: 11907109 [Abstract] [Full Text] [Related]
11. CD8+ cells are not necessary for allograft rejection or the induction of apoptosis in an experimental model of small intestinal transplantation. Krams SM, Hayashi M, Fox CK, Villanueva JC, Whitmer KJ, Burns W, Esquivel CO, Martinez OM. J Immunol; 1998 Apr 15; 160(8):3673-80. PubMed ID: 9558067 [Abstract] [Full Text] [Related]
12. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand. Miura Y, Thoburn CJ, Bright EC, Hess AD. Biol Blood Marrow Transplant; 2004 Mar 15; 10(3):156-70. PubMed ID: 14993881 [Abstract] [Full Text] [Related]
13. Islet allograft rejection by contact-dependent CD8+ T cells: perforin and FasL play alternate but obligatory roles. Sleater M, Diamond AS, Gill RG. Am J Transplant; 2007 Aug 15; 7(8):1927-33. PubMed ID: 17617855 [Abstract] [Full Text] [Related]
14. Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine. Merger M, Viney JL, Borojevic R, Steele-Norwood D, Zhou P, Clark DA, Riddell R, Maric R, Podack ER, Croitoru K. Gut; 2002 Aug 15; 51(2):155-63. PubMed ID: 12117872 [Abstract] [Full Text] [Related]
15. Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms. Kafrouni MI, Brown GR, Thiele DL. J Immunol; 2001 Aug 01; 167(3):1566-74. PubMed ID: 11466378 [Abstract] [Full Text] [Related]
16. The Fas/Fas ligand pathway is important for optimal tumor regression in a mouse model of CTL adoptive immunotherapy of experimental CMS4 lung metastases. Caldwell SA, Ryan MH, McDuffie E, Abrams SI. J Immunol; 2003 Sep 01; 171(5):2402-12. PubMed ID: 12928387 [Abstract] [Full Text] [Related]
17. In vivo analysis of adenovirus-specific cytotoxic T lymphocyte response in mice deficient in CD28, fas ligand, and perforin. Chen J, Hsu HC, Zajac AJ, Wu Q, Yang P, Xu X, McPherson SA, Li J, Curiel DT, Mountz JD. Hum Gene Ther; 2006 Jun 01; 17(6):669-82. PubMed ID: 16776575 [Abstract] [Full Text] [Related]
18. Intragraft activation of genes encoding cytotoxic T lymphocyte effector molecules precedes the histological evidence of rejection in human cardiac transplantation. Shulzhenko N, Morgun A, Zheng XX, Diniz RV, Almeida DR, Ma N, Strom TB, Gerbase-DeLima M. Transplantation; 2001 Nov 27; 72(10):1705-8. PubMed ID: 11726838 [Abstract] [Full Text] [Related]
19. The granule exocytosis and Fas/FasLigand pathways at the time of transplantation and during borderline and acute rejection of human renal allografts. Carstens J, Markussen N, Madsen M. Transplant Proc; 2005 Oct 27; 37(8):3294-7. PubMed ID: 16298578 [Abstract] [Full Text] [Related]
20. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand. Liu AN, Mohammed AZ, Rice WR, Fiedeldey DT, Liebermann JS, Whitsett JA, Braciale TJ, Enelow RI. Am J Respir Cell Mol Biol; 1999 May 27; 20(5):849-58. PubMed ID: 10226053 [Abstract] [Full Text] [Related] Page: [Next] [New Search]